Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
![Foto de Innovación, terapia y desarrollo farmacéutico en oftalmología](/img/grupo.png)
![Foto de Hospital Universitario San Cecilio](/img/noimage_org.png)
Hospital Universitario San Cecilio
Granada, EspañaPublications in collaboration with researchers from Hospital Universitario San Cecilio (10)
2021
-
Long-term Follow-up and optimization of infliximab in refractory uveitis due to Behçet Disease: National study of 103 white patients
Journal of Rheumatology, Vol. 48, Núm. 5, pp. 741-750
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2015
-
Specific association of IL17A genetic variants with panuveitis
British Journal of Ophthalmology, Vol. 99, Núm. 4, pp. 566-570
-
Study of association of CTLA4 gene variants to non-anterior uveitis
Tissue Antigens, Vol. 86, Núm. 5, pp. 373-376
2013
-
Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition
BMC Medical Genetics, Vol. 14, Núm. 1
-
No evidence of association between common autoimmunity STAT4 and IL23R risk polymorphisms and non-anterior uveitis
PLoS ONE, Vol. 8, Núm. 11
-
Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis
PLoS ONE, Vol. 8, Núm. 10
-
Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis
Mediators of Inflammation, Vol. 2013
2012
-
Treatment of refractory uveitis with adalimumab: A prospective multicenter study of 131 patients
Ophthalmology, Vol. 119, Núm. 8, pp. 1575-1581